Note: Certain portions of this document have been marked “[C.I.]” to indicate that confidential treatment has been requested for this confidential information. The confidential portions have been omitted and filed separately with the Securities and...Transition License Agreement • January 31st, 2008 • Dusa Pharmaceuticals Inc • Pharmaceutical preparations
This 2006 Micanol Transition License Agreement (the “Agreement”) is made as of January 29, 2008 (“Extension Effective Date”) by and between Winston Laboratories, Inc., a Delaware Corporation located at 100 Fairway Drive, Suite 134, Vernon Hills, Illinois 60061 (hereafter referred to as “Winston”) and Sirius Laboratories, Inc., a New Jersey Corporation with its principal offices at 25 Upton Drive, Wilmington, Massachusetts 01887 (hereinafter referred to as “Sirius”) being the successor in interest to Sirius Laboratories, Inc., the former Illinois corporation (the “Former Sirius”) (Winston and Sirius collectively called the “Parties”).
